ICATIBANT

ICATIBANT was reported 6011 times

ICATIBANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEREDITARY ANGIOEDEMA WITH C1 ESTERASE INHIBITOR DEFICIENCY 8 0.2286
1 SUPERNUMERARY TEETH 4 0.1538
2 C1 ESTERASE INHIBITOR DECREASED 2 0.1333
3 BODY HEIGHT INCREASED 57 0.1163
4 DEATH OF COMPANION 3 0.1154
5 HEREDITARY ANGIOEDEMA 1217 0.1133
6 BREAST ANGIOSARCOMA 2 0.0800
7 VASCULAR ACCESS SITE COMPLICATION 16 0.0635
8 COMPLEMENT DEFICIENCY DISEASE 2 0.0541
9 BODY HEIGHT ABNORMAL 6 0.0517
10 VACCINATION SITE SWELLING 4 0.0233
11 METASTATIC CARCINOID TUMOUR 2 0.0192
12 IDIOPATHIC ANGIOEDEMA 2 0.0192
13 DISCOURAGEMENT 41 0.0175
14 PTERYGIUM 6 0.0173
15 OVULATION DISORDER 2 0.0171
16 TOOTH AVULSION 3 0.0170
17 PARATRACHEAL LYMPHADENOPATHY 2 0.0164
18 ADMINISTRATION SITE PAIN 18 0.0156
19 GENITAL TRACT INFLAMMATION 3 0.0151
20 BREAST FEEDING 11 0.0141
21 LARYNGEAL DISORDER 10 0.0139
22 PUNCTURE SITE PAIN 3 0.0129
23 MACROGLOSSIA 7 0.0127
24 DEATH OF RELATIVE 5 0.0123
25 ADMINISTRATION SITE BRUISE 4 0.0115
26 ALLERGY TO PLANTS 5 0.0109
27 MOUTH CYST 2 0.0107
28 ERYTHEMA ANNULARE 3 0.0103
29 PHARYNGEAL SWELLING 96 0.0098
30 INSURANCE ISSUE 150 0.0098
31 STRESS AT WORK 11 0.0097
32 ALLERGY TO VACCINE 3 0.0097
33 ACCIDENT AT HOME 5 0.0097
34 SYNOVIAL RUPTURE 3 0.0087
35 ORAL CONTUSION 2 0.0087
36 EHLERS-DANLOS SYNDROME 4 0.0086
37 LARYNX IRRITATION 2 0.0085
38 NAIL BED INFECTION 2 0.0084
39 INJECTION SITE NERVE DAMAGE 2 0.0084
40 CRANIOFACIAL FRACTURE 7 0.0082
41 ADMINISTRATION SITE ERYTHEMA 2 0.0070
42 PRODUCT DISTRIBUTION ISSUE 64 0.0069
43 VEIN COLLAPSE 5 0.0065
44 INCARCERATED HERNIA 2 0.0065
45 MAST CELL ACTIVATION SYNDROME 9 0.0064
46 MASTOCYTOSIS 3 0.0063
47 SUSPECTED COVID-19 20 0.0061
48 PRODUCT AVAILABILITY ISSUE 137 0.0060
49 ARTHROPOD STING 10 0.0060
50 LARYNGEAL OEDEMA 37 0.0060
51 ACUTE STRESS DISORDER 2 0.0060
52 COVID-19 IMMUNISATION 5 0.0060
53 BOREDOM 2 0.0059
54 CIRCUMORAL OEDEMA 2 0.0057
55 PREGNANCY OF PARTNER 4 0.0056
56 FACIAL DISCOMFORT 4 0.0056
57 IMMUNISATION REACTION 4 0.0056
58 POST PROCEDURAL SWELLING 6 0.0055
59 HYPERTENSIVE URGENCY 3 0.0054
60 RESPIRATORY TRACT OEDEMA 4 0.0054
61 VEIN RUPTURE 9 0.0054
62 LUMBAR PUNCTURE 2 0.0053
63 UTERINE CYST 3 0.0053
64 COMPLICATION OF PREGNANCY 4 0.0053
65 TRACHEITIS 4 0.0052
66 LARYNGEAL STENOSIS 3 0.0052
67 OESOPHAGEAL INJURY 2 0.0052
68 PHYSICAL DECONDITIONING 13 0.0050
69 HEAT EXHAUSTION 4 0.0050
70 ANIMAL BITE 13 0.0049
71 POST PROCEDURAL INFLAMMATION 3 0.0048
72 ALLERGY TO CHEMICALS 6 0.0048
73 INFUSION SITE BRUISING 10 0.0046
74 FUNGAL FOOT INFECTION 2 0.0046
75 BODY HEIGHT DECREASED 46 0.0043
76 CENTRAL VENOUS CATHETER REMOVAL 2 0.0043
77 PULPITIS DENTAL 4 0.0042
78 INFUSION SITE HAEMATOMA 2 0.0042
79 ANIMAL SCRATCH 4 0.0041
80 LACTATION DISORDER 2 0.0041
81 IMMUNODEFICIENCY COMMON VARIABLE 2 0.0041
82 LIMB CRUSHING INJURY 3 0.0040
83 POOR VENOUS ACCESS 41 0.0040
84 MATERNAL EXPOSURE DURING BREAST FEEDING 16 0.0039
85 BRAIN NEOPLASM BENIGN 2 0.0039
86 INFUSION SITE DISCOMFORT 4 0.0039
87 EXPOSURE VIA BODY FLUID 3 0.0038
88 VASCULAR DEVICE INFECTION 17 0.0037
89 ABDOMINAL SYMPTOM 3 0.0037
90 PREGNANCY 73 0.0036
91 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 4 0.0036
92 MULTIPLE ALLERGIES 28 0.0036
93 MYCOTIC ALLERGY 3 0.0035
94 DOSE CALCULATION ERROR 2 0.0034
95 HEPATITIS C VIRUS TEST POSITIVE 2 0.0034
96 BLOOD OESTROGEN INCREASED 2 0.0034
97 ADENOMYOSIS 2 0.0034
98 CHEST INJURY 7 0.0034
99 ALLERGY TO METALS 2 0.0033
100 WEIGHT FLUCTUATION 34 0.0032
101 EXCESSIVE CERUMEN PRODUCTION 2 0.0032
102 LIMB MASS 7 0.0032
103 ACCIDENT AT WORK 7 0.0032
104 LARYNGEAL DISCOMFORT 2 0.0031
105 PRODUCT PRESCRIBING ERROR 73 0.0031
106 DELIVERY 2 0.0030
107 INFUSION SITE URTICARIA 2 0.0030
108 FOOD POISONING 16 0.0030
109 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 4 0.0030
110 SIALOADENITIS 4 0.0029
111 FACE INJURY 11 0.0029
112 PHYSICAL ASSAULT 6 0.0029
113 INFUSION SITE PRURITUS 9 0.0028
114 FOOD ALLERGY 22 0.0028
115 PELVIC FLUID COLLECTION 2 0.0028
116 FEAR OF DISEASE 5 0.0028
117 FEELING OF DESPAIR 13 0.0028
118 BITE 2 0.0028
119 SEASONAL ALLERGY 39 0.0028
120 ANGIOEDEMA 119 0.0027
121 OVARIAN NEOPLASM 2 0.0026
122 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 16 0.0026
123 MENOPAUSAL SYMPTOMS 6 0.0026
124 PRURITUS ALLERGIC 3 0.0026
125 DEPRESSIVE SYMPTOM 9 0.0026
126 PHARYNGEAL INFLAMMATION 3 0.0025
127 OROPHARYNGEAL DISCOMFORT 22 0.0024
128 DENTAL OPERATION 6 0.0024
129 THERAPEUTIC PRODUCT EFFECT DELAYED 11 0.0024
130 DENTAL DISCOMFORT 2 0.0024
131 ATONIC SEIZURES 2 0.0023
132 INJECTION SITE OEDEMA 4 0.0023
133 CENTRAL VENOUS CATHETERISATION 7 0.0023
134 LIPOMA 6 0.0023
135 TREATMENT DELAYED 4 0.0023
136 ADJUSTMENT DISORDER 3 0.0023
137 LIP INJURY 3 0.0023
138 BLOOD TRIGLYCERIDES ABNORMAL 2 0.0023
139 INFUSION SITE DISCOLOURATION 2 0.0023
140 GASTROINTESTINAL OEDEMA 4 0.0023
141 INFUSION SITE PAIN 29 0.0022
142 LIMB INJURY 61 0.0022
143 INTRA-ABDOMINAL FLUID COLLECTION 4 0.0022
144 INFECTIOUS MONONUCLEOSIS 5 0.0022
145 LIGAMENT SPRAIN 22 0.0022
146 URETERIC OBSTRUCTION 3 0.0022
147 BONE CONTUSION 2 0.0022
148 FOETAL HEART RATE ABNORMAL 2 0.0022
149 LOCALISED OEDEMA 10 0.0022
150 GLUTEN SENSITIVITY 3 0.0021
151 TRACHEOSTOMY 3 0.0021
152 CANCER SURGERY 2 0.0021
153 NONINFECTIVE GINGIVITIS 3 0.0021
154 APPLICATION SITE BRUISE 2 0.0021
155 MENTAL FATIGUE 3 0.0020
156 BREAST ABSCESS 2 0.0020
157 CORONAVIRUS TEST POSITIVE 2 0.0019
158 POST PROCEDURAL DISCOMFORT 4 0.0019
159 CARPAL TUNNEL DECOMPRESSION 2 0.0019
160 NASAL INFLAMMATION 2 0.0019
161 ARTHROPOD BITE 14 0.0019
162 HYDROCELE 2 0.0019
163 ABDOMINAL MASS 5 0.0019
164 TREATMENT NONCOMPLIANCE 102 0.0019
165 GASTROINTESTINAL INJURY 5 0.0019
166 SPINAL CORD DISORDER 3 0.0018
167 PRODUCT SUPPLY ISSUE 13 0.0018
168 RHINITIS ALLERGIC 8 0.0018
169 FEAR OF DEATH 4 0.0018
170 HEAVY MENSTRUAL BLEEDING 16 0.0018
171 METABOLIC SURGERY 2 0.0018
172 RESPIRATORY SYMPTOM 5 0.0018
173 EXPOSURE VIA BREAST MILK 7 0.0018
174 EXPIRED PRODUCT ADMINISTERED 58 0.0017
175 TONSILLITIS 9 0.0017
176 PAROTITIS 2 0.0017
177 ISCHAEMIC CEREBRAL INFARCTION 2 0.0017
178 APPENDICITIS 16 0.0017
179 NECK INJURY 5 0.0017
180 CONCUSSION 13 0.0017
181 MAGNETIC RESONANCE IMAGING ABNORMAL 2 0.0017
182 SKIN LACERATION 18 0.0017
183 EMERGENCY CARE 5 0.0016
184 POST-TRAUMATIC STRESS DISORDER 11 0.0016
185 EYE OEDEMA 4 0.0016
186 BODY TEMPERATURE ABNORMAL 3 0.0016
187 FAMILY STRESS 5 0.0016
188 RHINITIS 13 0.0016
189 VEIN DISORDER 8 0.0016
190 BILIARY OBSTRUCTION 2 0.0015
191 ABDOMINAL HERNIA 7 0.0015
192 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
193 UNDERWEIGHT 3 0.0015
194 PROTEIN TOTAL INCREASED 4 0.0015
195 FRUSTRATION TOLERANCE DECREASED 12 0.0015
196 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 5 0.0015
197 TRIGGER FINGER 6 0.0015
198 FACIAL PAIN 13 0.0015
199 APPLICATION SITE INFLAMMATION 2 0.0014
200 HORMONE LEVEL ABNORMAL 7 0.0014
201 PRODUCT USE ISSUE 268 0.0014
202 SLEEP DEFICIT 3 0.0014
203 PRODUCT DOSE OMISSION IN ERROR 40 0.0014
204 INJECTION SITE SCAR 4 0.0014
205 FEAR OF INJECTION 10 0.0014
206 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 2 0.0014
207 PHARYNGEAL DISORDER 4 0.0014
208 COLONOSCOPY 3 0.0014
209 LIGAMENT RUPTURE 6 0.0014
210 GENITAL PAIN 2 0.0014
211 SPINAL COLUMN INJURY 3 0.0013
212 ACCIDENT 16 0.0013
213 CHRONIC GASTRITIS 3 0.0013
214 INFUSION SITE ERYTHEMA 11 0.0013
215 INJECTION SITE PARAESTHESIA 2 0.0013
216 ECTOPIC PREGNANCY 4 0.0013
217 INFLUENZA 144 0.0013
218 UMBILICAL HERNIA 6 0.0013
219 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
220 WEIGHT INCREASED 285 0.0013
221 CONTRAST MEDIA REACTION 3 0.0013
222 FOREIGN BODY IN THROAT 4 0.0013
223 INGROWING NAIL 3 0.0013
224 JOINT DISLOCATION 13 0.0012
225 INJECTION RELATED REACTION 2 0.0012
226 PHARYNGITIS 15 0.0012
227 INABILITY TO AFFORD MEDICATION 12 0.0012
228 SKIN INJURY 4 0.0012
229 FOOD AVERSION 2 0.0012
230 BOWEL MOVEMENT IRREGULARITY 9 0.0012
231 PRODUCT DISPENSING ISSUE 5 0.0012
232 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
233 GASTROENTERITIS 17 0.0012
234 MENOPAUSE 3 0.0012
235 LYMPHOMA 18 0.0012
236 CATHETER SITE PAIN 3 0.0012
237 SENSITIVITY TO WEATHER CHANGE 6 0.0011
238 NEEDLE ISSUE 33 0.0011
239 KYPHOSIS 2 0.0011
240 BREAST CYST 2 0.0011
241 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 201 0.0011
242 INFUSION SITE SWELLING 7 0.0011
243 FACIAL BONES FRACTURE 4 0.0011
244 PRODUCT PRESCRIBING ISSUE 24 0.0011
245 ILLNESS 112 0.0011
246 SYNOVIAL CYST 5 0.0011
247 CHOLECYSTITIS INFECTIVE 3 0.0011
248 DENTAL CARE 2 0.0011
249 STREPTOCOCCAL INFECTION 6 0.0011
250 NECK MASS 3 0.0011
251 CORONAVIRUS INFECTION 7 0.0011
252 OXYGEN SATURATION ABNORMAL 3 0.0011
253 LIP DISORDER 2 0.0011
254 GUN SHOT WOUND 2 0.0011
255 GASTROENTERITIS VIRAL 19 0.0011
256 TOOTHACHE 19 0.0010
257 GASTRIC INFECTION 4 0.0010
258 POST PROCEDURAL COMPLICATION 20 0.0010
259 FIBULA FRACTURE 3 0.0010
260 HEPATIC MASS 2 0.0010
261 PRODUCT DOSE OMISSION ISSUE 305 0.0010
262 BILIARY COLIC 3 0.0010
263 COVID-19 180 0.0010
264 GASTROINTESTINAL INFLAMMATION 8 0.0010
265 PANCREATIC DISORDER 5 0.0010
266 GENE MUTATION 2 0.0010
267 GASTROINTESTINAL INFECTION 9 0.0010
268 OBSTRUCTION 4 0.0010
269 OVARIAN CYST 10 0.0010
270 WEIGHT DECREASED 279 0.0010
271 INTRACRANIAL ANEURYSM 4 0.0010
272 HAND FRACTURE 7 0.0010
273 THERMAL BURN 7 0.0010
274 INGUINAL HERNIA 6 0.0010
275 MUSCLE CONTRACTURE 2 0.0010
276 BREAST DISORDER 2 0.0010
277 ASPHYXIA 8 0.0010
278 COMPLICATION ASSOCIATED WITH DEVICE 14 0.0010
279 GASTRITIS 25 0.0009
280 SENSITIVE SKIN 7 0.0009
281 EAR SWELLING 2 0.0009
282 INJECTION SITE URTICARIA 23 0.0009
283 PROCEDURAL PAIN 26 0.0009
284 JOINT INJURY 20 0.0009
285 INJECTION SITE DISCHARGE 5 0.0009
286 GINGIVITIS 5 0.0009
287 PRODUCT PREPARATION ISSUE 6 0.0009
288 MELANOCYTIC NAEVUS 4 0.0009
289 TOOTH INFECTION 12 0.0009
290 ENDOMETRIAL CANCER 2 0.0009
291 NEAR DEATH EXPERIENCE 3 0.0009
292 UPPER LIMB FRACTURE 18 0.0009
293 NEPHROLITHIASIS 41 0.0009
294 GASTRIC POLYPS 2 0.0009
295 DRUG EFFECT LESS THAN EXPECTED 13 0.0009
296 DENGUE FEVER 2 0.0009
297 BRAIN OEDEMA 11 0.0009
298 DEPRESSED MOOD 46 0.0009
299 CERVICAL VERTEBRAL FRACTURE 3 0.0009
300 INTENTIONAL PRODUCT USE ISSUE 76 0.0009
301 HYPOPNOEA 3 0.0009
302 APHONIA 12 0.0009
303 SCRATCH 9 0.0009
304 CRYING 31 0.0009
305 SKIN ABRASION 4 0.0008
306 APPENDICECTOMY 3 0.0008
307 ODYNOPHAGIA 5 0.0008
308 NASAL CONGESTION 49 0.0008
309 GASTROINTESTINAL OBSTRUCTION 2 0.0008
310 DYSMENORRHOEA 11 0.0008
311 PAINFUL RESPIRATION 2 0.0008
312 HERNIA 16 0.0008
313 EAR INFECTION 22 0.0008
314 BRONCHITIS CHRONIC 2 0.0008
315 ORAL DISORDER 6 0.0008
316 HAEMATOLOGICAL INFECTION 2 0.0008
317 KIDNEY INFECTION 16 0.0008
318 MENISCUS INJURY 5 0.0008
319 PSYCHIATRIC SYMPTOM 6 0.0008
320 WOUND HAEMORRHAGE 3 0.0008
321 MUSCLE STRAIN 7 0.0008
322 ANEURYSM 4 0.0008
323 GASTROINTESTINAL TUBE INSERTION 2 0.0008
324 AUTOIMMUNE THYROIDITIS 3 0.0008
325 INJECTION SITE BRUISING 63 0.0008
326 ABDOMINAL INFECTION 2 0.0008
327 ENDOCARDITIS 4 0.0008
328 INJECTION SITE SWELLING 59 0.0008
329 ROAD TRAFFIC ACCIDENT 32 0.0008
330 TOOTH DISORDER 17 0.0008
331 AFFECTIVE DISORDER 6 0.0008
332 INJECTION SITE DISCOMFORT 8 0.0008
333 INFLAMMATION 39 0.0008
334 HYPERPHAGIA 3 0.0008
335 NASAL DISORDER 2 0.0008
336 BREAST MASS 5 0.0007
337 FEAR 20 0.0007
338 PERIPHERAL VENOUS DISEASE 3 0.0007
339 INJECTION SITE ERYTHEMA 90 0.0007
340 SOCIAL PROBLEM 3 0.0007
341 VIRAL INFECTION 24 0.0007
342 EAR PAIN 14 0.0007
343 INTERMENSTRUAL BLEEDING 4 0.0007
344 ONYCHOMADESIS 3 0.0007
345 ENDOTRACHEAL INTUBATION 2 0.0007
346 PERIORBITAL SWELLING 4 0.0007
347 INJECTION SITE IRRITATION 9 0.0007
348 BREAST CANCER STAGE IV 2 0.0007
349 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
350 POOR QUALITY SLEEP 15 0.0007
351 HEAD INJURY 22 0.0007
352 PYELONEPHRITIS 6 0.0007
353 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
354 INJECTION SITE PAIN 211 0.0007
355 TOOTH ABSCESS 7 0.0007
356 SYRINGE ISSUE 12 0.0007
357 NEGATIVE THOUGHTS 2 0.0007
358 APPLICATION SITE PAIN 15 0.0007
359 ABDOMINAL DISTENSION 71 0.0007
360 COVID-19 PNEUMONIA 8 0.0007
361 SWOLLEN TONGUE 21 0.0007
362 INFUSION SITE REACTION 2 0.0007
363 RESPIRATORY DISORDER 20 0.0007
364 HIV INFECTION 2 0.0007
365 CYSTITIS 21 0.0007
366 EYE INJURY 2 0.0007
367 NEURALGIA 16 0.0007
368 DYSCHEZIA 2 0.0007
369 INJECTION SITE REACTION 45 0.0007
370 MASTICATION DISORDER 2 0.0007
371 PROCEDURAL COMPLICATION 5 0.0007
372 DEVICE RELATED INFECTION 10 0.0006
373 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
374 MUSCULOSKELETAL CHEST PAIN 10 0.0006
375 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
376 DISCOMFORT 39 0.0006
377 INTESTINAL OBSTRUCTION 24 0.0006
378 GASTROINTESTINAL PAIN 7 0.0006
379 TOOTH FRACTURE 7 0.0006
380 PRODUCT USE COMPLAINT 10 0.0006
381 BREAST CANCER RECURRENT 2 0.0006
382 FOOT FRACTURE 12 0.0006
383 DENTAL CARIES 7 0.0006
384 NON-CARDIAC CHEST PAIN 2 0.0006
385 BLADDER PAIN 2 0.0006
386 ENDOMETRIOSIS 3 0.0006
387 SCIATICA 10 0.0006
388 INJECTION SITE PRURITUS 42 0.0006
389 EYE INFECTION 7 0.0006
390 MYASTHENIA GRAVIS 5 0.0006
391 INJECTION SITE INDURATION 8 0.0006
392 GASTROINTESTINAL DISORDER 55 0.0006
393 DERMATITIS CONTACT 7 0.0006
394 NEOPLASM 7 0.0006
395 BEDRIDDEN 8 0.0006
396 BLOOD PRESSURE ABNORMAL 12 0.0006
397 EXPIRED DEVICE USED 2 0.0006
398 INJECTION SITE INFLAMMATION 3 0.0006
399 APPLICATION SITE SWELLING 3 0.0006
400 PROTEIN URINE PRESENT 3 0.0006
401 SALIVARY HYPERSECRETION 6 0.0006
402 MENINGITIS 4 0.0006
403 SPLENOMEGALY 7 0.0006
404 SENSATION OF FOREIGN BODY 5 0.0006
405 POSTOPERATIVE WOUND INFECTION 4 0.0006
406 HEPATIC CYST 2 0.0006
407 PHLEBITIS 3 0.0006
408 ECCHYMOSIS 4 0.0006
409 PRODUCT CONTAINER ISSUE 5 0.0006
410 TENDONITIS 9 0.0006
411 JOINT EFFUSION 4 0.0006
412 BRAIN FOG 9 0.0006
413 MASS 8 0.0006
414 CATARACT 34 0.0006
415 SWELLING 53 0.0006
416 RENAL PAIN 6 0.0006
417 OBESITY 9 0.0006
418 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
419 INJECTION SITE RASH 17 0.0006
420 MENTAL DISORDER 24 0.0006
421 PULMONARY THROMBOSIS 6 0.0005
422 CHOLELITHIASIS 18 0.0005
423 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
424 NONSPECIFIC REACTION 3 0.0005
425 DEAFNESS UNILATERAL 3 0.0005
426 CHOKING SENSATION 3 0.0005
427 ADVERSE EVENT 50 0.0005
428 HIATUS HERNIA 7 0.0005
429 CHRONIC SINUSITIS 2 0.0005
430 PREMATURE LABOUR 3 0.0005
431 CATHETER SITE INFECTION 2 0.0005
432 BURNING SENSATION 37 0.0005
433 MUSCULOSKELETAL DISCOMFORT 9 0.0005
434 INFLUENZA LIKE ILLNESS 43 0.0005
435 CLAVICLE FRACTURE 2 0.0005
436 MOUTH SWELLING 3 0.0005
437 EATING DISORDER 11 0.0005
438 DYSURIA 19 0.0005
439 MUSCLE RUPTURE 2 0.0005
440 CERVIX CARCINOMA 2 0.0005
441 SKIN CANCER 11 0.0005
442 HEAD DISCOMFORT 9 0.0005
443 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
444 OESOPHAGEAL PAIN 2 0.0005
445 SINUS DISORDER 10 0.0005
446 MIGRAINE 48 0.0005
447 WRIST FRACTURE 6 0.0005
448 CARPAL TUNNEL SYNDROME 7 0.0005
449 MALAISE 219 0.0005
450 RESPIRATORY TRACT INFECTION 13 0.0005
451 BRAIN INJURY 5 0.0005
452 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
453 SINUSITIS 51 0.0005
454 OROPHARYNGEAL PAIN 46 0.0005
455 DYSPHONIA 29 0.0005
456 ABDOMINAL PAIN 115 0.0005
457 FIBROMYALGIA 12 0.0005
458 BACK DISORDER 8 0.0005
459 RIB FRACTURE 10 0.0005
460 ANAPHYLACTOID REACTION 2 0.0005
461 TENDON RUPTURE 6 0.0005
462 PIGMENTATION DISORDER 3 0.0005
463 TEMPERATURE INTOLERANCE 5 0.0005
464 INJECTION SITE DISCOLOURATION 6 0.0005
465 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
466 BLOOD URINE PRESENT 9 0.0005
467 BRONCHITIS 35 0.0005
468 LIP OEDEMA 2 0.0005
469 AORTIC VALVE INCOMPETENCE 2 0.0005
470 PULMONARY MASS 7 0.0005
471 ABSCESS LIMB 2 0.0005
472 DIVERTICULITIS 13 0.0005
473 SCAR 8 0.0005
474 HAEMATOMA 12 0.0005
475 HORDEOLUM 2 0.0005
476 HYSTERECTOMY 4 0.0005
477 POLYP 3 0.0005
478 IMMOBILE 2 0.0005
479 IMMUNE SYSTEM DISORDER 6 0.0005
480 ABDOMINAL ABSCESS 2 0.0005
481 ANAPHYLACTIC REACTION 25 0.0005
482 LIMB DISCOMFORT 14 0.0005
483 BLOOD PRESSURE DECREASED 30 0.0005
484 SYSTEMIC LUPUS ERYTHEMATOSUS 16 0.0005
485 EYE HAEMORRHAGE 6 0.0004
486 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
487 SKIN MASS 3 0.0004
488 HOSPITALISATION 69 0.0004
489 GALLBLADDER DISORDER 8 0.0004
490 CONTUSION 43 0.0004
491 MENINGITIS ASEPTIC 2 0.0004
492 NASOPHARYNGITIS 82 0.0004
493 IRON DEFICIENCY 2 0.0004
494 FEEDING DISORDER 9 0.0004
495 FALL 147 0.0004
496 NERVOUSNESS 23 0.0004
497 SPEECH DISORDER 23 0.0004
498 CHOLECYSTECTOMY 5 0.0004
499 IMMUNE THROMBOCYTOPENIA 2 0.0004
500 BRAIN NEOPLASM 4 0.0004
501 RESPIRATION ABNORMAL 3 0.0004
502 LYMPHOEDEMA 3 0.0004
503 CHRONIC MYELOID LEUKAEMIA 2 0.0004
504 ORAL DISCOMFORT 6 0.0004
505 CONJUNCTIVITIS 8 0.0004
506 POST PROCEDURAL HAEMORRHAGE 5 0.0004
507 DIARRHOEA HAEMORRHAGIC 4 0.0004
508 INJURY 30 0.0004
509 PAPULE 3 0.0004
510 URTICARIA 71 0.0004
511 EMOTIONAL DISORDER 13 0.0004
512 EXPOSURE DURING PREGNANCY 26 0.0004
513 LIMB OPERATION 2 0.0004
514 LOWER LIMB FRACTURE 8 0.0004
515 PANIC REACTION 3 0.0004
516 FACE OEDEMA 7 0.0004
517 TONGUE DISORDER 3 0.0004
518 ANOSMIA 6 0.0004
519 LOCALISED INFECTION 10 0.0004
520 MAJOR DEPRESSION 3 0.0004
521 AUTOIMMUNE DISORDER 4 0.0004
522 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
523 THERAPY CHANGE 4 0.0004
524 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
525 MOOD ALTERED 11 0.0004
526 BLADDER DISORDER 4 0.0004
527 NO ADVERSE EVENT 72 0.0004
528 PRODUCT USE IN UNAPPROVED INDICATION 98 0.0004
529 WOUND 11 0.0004
530 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
531 LIP SWELLING 13 0.0004
532 SWELLING FACE 25 0.0004
533 MALABSORPTION 2 0.0004
534 HYPERSENSITIVITY 71 0.0004
535 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
536 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
537 SYNCOPE 38 0.0004
538 THROAT IRRITATION 17 0.0004
539 INCONTINENCE 4 0.0004
540 BACTERIAL INFECTION 7 0.0004
541 URINARY TRACT INFECTION 64 0.0004
542 BREAST PAIN 4 0.0004
543 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
544 LOSS OF CONSCIOUSNESS 48 0.0004
545 IRRITABLE BOWEL SYNDROME 8 0.0004
546 SEIZURE 43 0.0004
547 RASH MACULAR 13 0.0004
548 PHARYNGITIS STREPTOCOCCAL 4 0.0004
549 POST PROCEDURAL INFECTION 3 0.0004
550 BACK INJURY 4 0.0004
551 PALLOR 10 0.0004
552 IMPAIRED GASTRIC EMPTYING 5 0.0004
553 ABNORMAL FAECES 3 0.0004
554 HEADACHE 229 0.0004
555 ASPIRATION 4 0.0004
556 CONDITION AGGRAVATED 111 0.0004
557 ESCHERICHIA INFECTION 3 0.0004
558 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
559 CARDIAC DISORDER 34 0.0004
560 PRESCRIBED OVERDOSE 7 0.0004
561 HEMIPLEGIA 3 0.0004
562 OCULAR DISCOMFORT 4 0.0004
563 FACIAL PARALYSIS 3 0.0004
564 CHEST PAIN 65 0.0004
565 INTERNAL HAEMORRHAGE 4 0.0003
566 NEUROLOGICAL SYMPTOM 2 0.0003
567 THERAPY INTERRUPTED 25 0.0003
568 ABDOMINAL PAIN UPPER 72 0.0003
569 ABORTION SPONTANEOUS 14 0.0003
570 SPINAL FRACTURE 7 0.0003
571 MOBILITY DECREASED 25 0.0003
572 EXERCISE TOLERANCE DECREASED 2 0.0003
573 PRODUCT ADMINISTRATION ERROR 7 0.0003
574 URINE OUTPUT DECREASED 3 0.0003
575 GROIN PAIN 3 0.0003
576 SPINAL PAIN 4 0.0003
577 GRIP STRENGTH DECREASED 3 0.0003
578 INJECTION SITE WARMTH 7 0.0003
579 HYPERCHLORHYDRIA 2 0.0003
580 ANXIETY 96 0.0003
581 BACK PAIN 78 0.0003
582 THROMBOSIS 27 0.0003
583 PRODUCTIVE COUGH 16 0.0003
584 FOETAL GROWTH RESTRICTION 2 0.0003
585 NERVE COMPRESSION 3 0.0003
586 PHARYNGEAL OEDEMA 5 0.0003
587 THYROID DISORDER 5 0.0003
588 PNEUMONIA 105 0.0003
589 FEELING COLD 9 0.0003
590 GENERALISED OEDEMA 4 0.0003
591 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
592 CYST 4 0.0003
593 ILEUS 4 0.0003
594 INFUSION SITE EXTRAVASATION 2 0.0003
595 OXYGEN SATURATION DECREASED 18 0.0003
596 FLANK PAIN 3 0.0003
597 SECRETION DISCHARGE 4 0.0003
598 DERMATITIS ALLERGIC 4 0.0003
599 LEUKAEMIA 3 0.0003
600 INFECTION 46 0.0003
601 SPINAL DISORDER 3 0.0003
602 ABDOMINAL PAIN LOWER 8 0.0003
603 PRODUCT PACKAGING ISSUE 3 0.0003
604 INTENTIONAL DOSE OMISSION 9 0.0003
605 PNEUMOTHORAX 5 0.0003
606 EYE INFLAMMATION 3 0.0003
607 SLEEP APNOEA SYNDROME 6 0.0003
608 MATERNAL EXPOSURE DURING PREGNANCY 28 0.0003
609 HYPERSOMNIA 9 0.0003
610 COUGH 88 0.0003
611 HYPOTHYROIDISM 10 0.0003
612 VERTIGO 19 0.0003
613 AFFECT LABILITY 3 0.0003
614 ERUCTATION 6 0.0003
615 DEAFNESS 8 0.0003
616 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
617 NECK PAIN 17 0.0003
618 PANIC ATTACK 11 0.0003
619 APPETITE DISORDER 2 0.0003
620 GAIT INABILITY 10 0.0003
621 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
622 QUALITY OF LIFE DECREASED 4 0.0003
623 ABDOMINAL DISCOMFORT 50 0.0003
624 INJECTION SITE MASS 11 0.0003
625 DRUG INEFFECTIVE 391 0.0003
626 METASTASES TO LYMPH NODES 2 0.0003
627 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
628 TASTE DISORDER 6 0.0003
629 DYSPHAGIA 28 0.0003
630 INJURY ASSOCIATED WITH DEVICE 6 0.0003
631 RHINORRHOEA 19 0.0003
632 GINGIVAL BLEEDING 4 0.0003
633 EAR DISCOMFORT 3 0.0003
634 HELICOBACTER INFECTION 3 0.0003
635 DROOLING 2 0.0003
636 CARDIO-RESPIRATORY ARREST 12 0.0003
637 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
638 VOMITING 134 0.0003
639 NEOPLASM MALIGNANT 19 0.0003
640 BLINDNESS UNILATERAL 4 0.0003
641 PAIN 173 0.0003
642 PARAESTHESIA ORAL 4 0.0003
643 MENSTRUATION DELAYED 3 0.0003
644 OEDEMA 15 0.0003
645 OSTEOMYELITIS 5 0.0003
646 HYPOKINESIA 4 0.0003
647 FAECES SOFT 2 0.0003
648 BLOOD PRESSURE INCREASED 42 0.0003
649 APATHY 4 0.0003
650 INTENTIONAL UNDERDOSE 2 0.0003
651 EYE DISORDER 9 0.0003
652 SURGERY 16 0.0003
653 MOUTH HAEMORRHAGE 2 0.0003
654 PERIPHERAL SWELLING 42 0.0003
655 ANAPHYLACTIC SHOCK 7 0.0003
656 FUNGAL INFECTION 9 0.0003
657 THINKING ABNORMAL 5 0.0003
658 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
659 CHEST DISCOMFORT 27 0.0003
660 PRODUCT STORAGE ERROR 23 0.0003
661 HAEMODYNAMIC INSTABILITY 2 0.0003
662 THROAT TIGHTNESS 7 0.0003
663 ATRIOVENTRICULAR BLOCK 2 0.0003
664 ANKLE FRACTURE 4 0.0003
665 PELVIC FRACTURE 2 0.0003
666 CHOKING 5 0.0003
667 BONE PAIN 15 0.0003
668 PYREXIA 88 0.0003
669 ARTHRITIS 20 0.0003
670 RESPIRATORY DISTRESS 7 0.0003
671 SOMNOLENCE 51 0.0003
672 ARTHROPATHY 14 0.0003
673 INSOMNIA 67 0.0003
674 GINGIVAL PAIN 2 0.0003
675 HYPERLIPIDAEMIA 3 0.0003
676 FEELING ABNORMAL 60 0.0003
677 MOVEMENT DISORDER 8 0.0002
678 THERAPY NON-RESPONDER 11 0.0002
679 STAPHYLOCOCCAL INFECTION 8 0.0002
680 EYE SWELLING 9 0.0002
681 MENSTRUAL DISORDER 2 0.0002
682 TOOTH EXTRACTION 3 0.0002
683 EMBOLISM 2 0.0002
684 PULMONARY HYPERTENSION 5 0.0002
685 RASH PRURITIC 13 0.0002
686 HAEMORRHAGE 25 0.0002
687 DIZZINESS 119 0.0002
688 KNEE ARTHROPLASTY 5 0.0002
689 COLITIS 9 0.0002
690 RENAL DISORDER 11 0.0002
691 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
692 FLUID RETENTION 12 0.0002
693 ROTATOR CUFF SYNDROME 3 0.0002
694 SEPSIS 26 0.0002
695 BLOOD POTASSIUM DECREASED 7 0.0002
696 CARDIAC OPERATION 2 0.0002
697 DEHYDRATION 31 0.0002
698 ASTHENIA 87 0.0002
699 CHILLS 27 0.0002
700 ASTHMA 26 0.0002
701 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
702 APPLICATION SITE ERYTHEMA 6 0.0002
703 ORAL CANDIDIASIS 3 0.0002
704 DISORIENTATION 9 0.0002
705 LIVER DISORDER 10 0.0002
706 DEPRESSION 51 0.0002
707 ISCHAEMIC STROKE 4 0.0002
708 SNEEZING 5 0.0002
709 MYOSITIS 2 0.0002
710 SINUS CONGESTION 3 0.0002
711 PELVIC PAIN 4 0.0002
712 MEMORY IMPAIRMENT 30 0.0002
713 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
714 APPLICATION SITE RASH 3 0.0002
715 IRRITABILITY 13 0.0002
716 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
717 DEMENTIA 6 0.0002
718 GAIT DISTURBANCE 41 0.0002
719 TACHYCARDIA 19 0.0002
720 DIARRHOEA 138 0.0002
721 ABORTION INDUCED 2 0.0002
722 MYALGIA 36 0.0002
723 INFUSION RELATED REACTION 14 0.0002
724 MUSCULAR WEAKNESS 24 0.0002
725 ACNE 16 0.0002
726 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
727 BRONCHOSPASM 3 0.0002
728 URINARY RETENTION 7 0.0002
729 HYPERHIDROSIS 27 0.0002
730 ERYTHEMA 43 0.0002
731 PANCREATITIS 11 0.0002
732 TYPE 2 DIABETES MELLITUS 7 0.0002
733 GLAUCOMA 4 0.0002
734 VAGINAL HAEMORRHAGE 9 0.0002
735 PAIN IN EXTREMITY 61 0.0002
736 PRESYNCOPE 5 0.0002
737 LUNG DISORDER 10 0.0002
738 KNEE OPERATION 2 0.0002
739 HOSPICE CARE 2 0.0002
740 DECREASED APPETITE 47 0.0002
741 COLON CANCER 3 0.0002
742 EPISTAXIS 15 0.0002
743 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
744 AGEUSIA 5 0.0002
745 INJECTION SITE HAEMORRHAGE 16 0.0002
746 AMNESIA 13 0.0002
747 DYSPNOEA 113 0.0002
748 HEART RATE DECREASED 7 0.0002
749 HYPOAESTHESIA ORAL 3 0.0002
750 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
751 LACRIMATION INCREASED 6 0.0002
752 UNEVALUABLE EVENT 15 0.0002
753 HYPOTHERMIA 2 0.0002
754 GASTRIC CANCER 5 0.0002
755 NAUSEA 156 0.0002
756 DRY THROAT 2 0.0002
757 OFF LABEL USE 172 0.0002
758 HIP ARTHROPLASTY 3 0.0002
759 SKIN DISCOLOURATION 9 0.0002
760 INITIAL INSOMNIA 2 0.0002
761 EYE DISCHARGE 2 0.0002
762 NERVOUS SYSTEM DISORDER 6 0.0002
763 HEART RATE INCREASED 19 0.0002
764 HERPES ZOSTER 11 0.0002
765 PRODUCT SUBSTITUTION ISSUE 11 0.0002
766 MYOCARDIAL INFARCTION 33 0.0002
767 INCORRECT DOSE ADMINISTERED 43 0.0002
768 IMPAIRED WORK ABILITY 4 0.0002
769 HYPOAESTHESIA 28 0.0002
770 MENSTRUATION IRREGULAR 5 0.0002
771 DECREASED ACTIVITY 2 0.0002
772 MUSCLE SPASMS 34 0.0002
773 BLOOD POTASSIUM INCREASED 3 0.0002
774 DYSPEPSIA 18 0.0002
775 COAGULOPATHY 3 0.0002
776 NERVE INJURY 2 0.0002
777 FATIGUE 140 0.0002
778 HYPERTENSIVE CRISIS 2 0.0002
779 PALPITATIONS 21 0.0002
780 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
781 PERICARDITIS 3 0.0002
782 EYE PRURITUS 6 0.0002
783 DEVICE ISSUE 16 0.0002
784 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
785 INTESTINAL PERFORATION 2 0.0002
786 CHROMATURIA 4 0.0002
787 FLATULENCE 10 0.0002
788 ARTHRALGIA 73 0.0002
789 THERAPY CESSATION 9 0.0002
790 MICTURITION URGENCY 2 0.0002
791 TINNITUS 8 0.0002
792 METASTASES TO LUNG 2 0.0002
793 OEDEMA PERIPHERAL 21 0.0002
794 ELECTROLYTE IMBALANCE 2 0.0002
795 EYELID OEDEMA 2 0.0002
796 BLOOD CHOLESTEROL INCREASED 8 0.0002
797 DYSSTASIA 5 0.0002
798 DIABETES MELLITUS 13 0.0002
799 COLD SWEAT 3 0.0002
800 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
801 PRURITUS 65 0.0002
802 TREMOR 28 0.0002
803 OCULAR HYPERAEMIA 8 0.0002
804 BLOOD IRON DECREASED 2 0.0002
805 CHOLECYSTITIS 2 0.0002
806 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
807 BURSITIS 2 0.0002
808 BONE DISORDER 3 0.0002
809 SUICIDAL IDEATION 15 0.0002
810 FEELING HOT 10 0.0002
811 HAEMATOCHEZIA 9 0.0002
812 BLOOD GLUCOSE ABNORMAL 3 0.0002
813 INJECTION SITE EXTRAVASATION 2 0.0002
814 CONSTIPATION 35 0.0002
815 MUSCULOSKELETAL STIFFNESS 14 0.0002
816 CEREBROVASCULAR ACCIDENT 27 0.0002
817 CELLULITIS 8 0.0002
818 GASTRIC ULCER 3 0.0002
819 HAEMATEMESIS 4 0.0002
820 DRUG RESISTANCE 4 0.0002
821 HAEMORRHOIDS 3 0.0002
822 NODULE 2 0.0002
823 BREAST CANCER 14 0.0002
824 MALIGNANT MELANOMA 2 0.0001
825 EMOTIONAL DISTRESS 18 0.0001
826 FREQUENT BOWEL MOVEMENTS 4 0.0001
827 ANGER 5 0.0001
828 BLINDNESS 6 0.0001
829 BODY TEMPERATURE INCREASED 3 0.0001
830 SKIN LESION 4 0.0001
831 RESPIRATORY ARREST 4 0.0001
832 NIGHTMARE 5 0.0001
833 HAEMOPTYSIS 4 0.0001
834 BLISTER 8 0.0001
835 DEVICE OCCLUSION 2 0.0001
836 PAIN IN JAW 4 0.0001
837 PARALYSIS 2 0.0001
838 ANGINA PECTORIS 4 0.0001
839 IMPAIRED QUALITY OF LIFE 2 0.0001
840 BALANCE DISORDER 12 0.0001
841 FAECES DISCOLOURED 3 0.0001
842 HYPERTHYROIDISM 2 0.0001
843 INJECTION SITE HAEMATOMA 2 0.0001
844 PRODUCT DISPENSING ERROR 3 0.0001
845 PULMONARY EMBOLISM 13 0.0001
846 ACUTE MYOCARDIAL INFARCTION 4 0.0001
847 DRUG WITHDRAWAL SYNDROME NEONATAL 2 0.0001
848 IMMUNODEFICIENCY 2 0.0001
849 ECONOMIC PROBLEM 2 0.0001
850 OSTEOPENIA 2 0.0001
851 VISION BLURRED 18 0.0001
852 EPILEPSY 4 0.0001
853 PERICARDIAL EFFUSION 3 0.0001
854 BASAL CELL CARCINOMA 2 0.0001
855 CYANOSIS 2 0.0001
856 RASH 55 0.0001
857 ABSCESS 2 0.0001
858 HIP FRACTURE 4 0.0001
859 JOINT SWELLING 15 0.0001
860 EYE PAIN 7 0.0001
861 UNDERDOSE 9 0.0001
862 ATRIAL FIBRILLATION 12 0.0001
863 HYPERTENSION 26 0.0001
864 LIVER INJURY 3 0.0001
865 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
866 SKIN DISORDER 4 0.0001
867 POLLAKIURIA 5 0.0001
868 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
869 HEMIPARESIS 2 0.0001
870 HYPOPHAGIA 3 0.0001
871 RECTAL HAEMORRHAGE 5 0.0001
872 SUICIDE ATTEMPT 7 0.0001
873 DEVICE DEFECTIVE 2 0.0001
874 PLEURAL EFFUSION 7 0.0001
875 ECZEMA 6 0.0001
876 MUSCULOSKELETAL PAIN 6 0.0001
877 PARAESTHESIA 18 0.0001
878 INTENTIONAL PRODUCT MISUSE 10 0.0001
879 AMENORRHOEA 2 0.0001
880 METASTASES TO LIVER 2 0.0001
881 SLEEP DISORDER 8 0.0001
882 BRADYCARDIA 6 0.0001
883 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
884 LYMPHADENOPATHY 4 0.0001
885 DRUG ERUPTION 2 0.0001
886 BREAST CANCER FEMALE 3 0.0001
887 GOUT 2 0.0001
888 PAIN OF SKIN 3 0.0001
889 AGITATION 8 0.0001
890 TREATMENT FAILURE 9 0.0001
891 HEPATIC STEATOSIS 2 0.0001
892 HEPATIC CIRRHOSIS 2 0.0001
893 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
894 DEVICE DIFFICULT TO USE 7 0.0001
895 ARRHYTHMIA 5 0.0001
896 NEUROPATHY PERIPHERAL 10 0.0001
897 FEELING JITTERY 2 0.0001
898 INCREASED APPETITE 2 0.0001
899 RASH ERYTHEMATOUS 5 0.0001
900 BLOOD GLUCOSE DECREASED 5 0.0001
901 PREMATURE BABY 3 0.0001
902 PROSTATE CANCER 8 0.0001
903 APHASIA 3 0.0001
904 INTENTIONAL SELF-INJURY 2 0.0001
905 STOMATITIS 6 0.0001
906 DRY MOUTH 8 0.0001
907 DYSKINESIA 4 0.0001
908 MOUTH ULCERATION 2 0.0001
909 OSTEOARTHRITIS 4 0.0001
910 MOOD SWINGS 3 0.0001
911 NIGHT SWEATS 3 0.0001
912 DEVICE LEAKAGE 4 0.0001
913 DEATH 79 0.0001
914 ORAL PAIN 2 0.0001
915 ADVERSE DRUG REACTION 8 0.0001
916 APPLICATION SITE PRURITUS 2 0.0001
917 GASTRIC DISORDER 3 0.0001
918 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
919 COGNITIVE DISORDER 4 0.0001
920 WHEEZING 5 0.0001
921 ANAEMIA 16 0.0001
922 BLOOD PRESSURE FLUCTUATION 2 0.0001
923 SKIN EXFOLIATION 7 0.0001
924 RESPIRATORY FAILURE 6 0.0001
925 VISUAL IMPAIRMENT 10 0.0001
926 FLUSHING 8 0.0001
927 HEPATITIS 2 0.0001
928 CARDIAC FAILURE 6 0.0001
929 JAUNDICE 2 0.0001
930 EXTRA DOSE ADMINISTERED 3 0.0001
931 ABNORMAL DREAMS 2 0.0001
932 DEVICE MALFUNCTION 5 0.0001
933 RHEUMATOID ARTHRITIS 8 0.0001
934 HYPOACUSIS 3 0.0001
935 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
936 LABORATORY TEST ABNORMAL 2 0.0001
937 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
938 PRODUCT QUALITY ISSUE 9 0.0001
939 THERAPEUTIC RESPONSE DECREASED 4 0.0001
940 SKIN IRRITATION 3 0.0001
941 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
942 COMA 3 0.0001
943 RENAL CANCER 3 0.0001
944 MULTIPLE SCLEROSIS 3 0.0001
945 CARDIAC FAILURE CONGESTIVE 5 0.0001
946 RENAL FAILURE 8 0.0001
947 DRY EYE 3 0.0001
948 AGGRESSION 3 0.0001
949 HYPOXIA 2 0.0001
950 ALOPECIA 11 0.0001
951 CEREBRAL HAEMORRHAGE 2 0.0001
952 CONFUSIONAL STATE 9 0.0001
953 DISTURBANCE IN ATTENTION 3 0.0001
954 MEDICATION ERROR 3 0.0001
955 DYSARTHRIA 2 0.0001
956 DYSPNOEA EXERTIONAL 2 0.0001
957 DRY SKIN 7 0.0001
958 LETHARGY 3 0.0001
959 OVERDOSE 11 0.0001
960 ABNORMAL BEHAVIOUR 2 0.0001
961 HYPOTENSION 10 0.0000
962 DEVICE BREAKAGE 2 0.0000
963 HAEMOGLOBIN DECREASED 5 0.0000
964 LUNG NEOPLASM MALIGNANT 2 0.0000
965 CARDIAC ARREST 4 0.0000
966 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
967 RENAL IMPAIRMENT 4 0.0000
968 COLITIS ULCERATIVE 2 0.0000
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
970 HYPOGLYCAEMIA 2 0.0000
971 CHRONIC KIDNEY DISEASE 3 0.0000
972 BLOOD GLUCOSE INCREASED 7 0.0000
973 ILL-DEFINED DISORDER 2 0.0000
974 DRUG INTERACTION 5 0.0000
975 DEEP VEIN THROMBOSIS 2 0.0000
976 BLOOD CREATININE INCREASED 2 0.0000
977 HEPATIC ENZYME INCREASED 2 0.0000
978 PLATELET COUNT DECREASED 3 0.0000
979 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
980 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
981 DYSGEUSIA 2 0.0000
982 HOT FLUSH 2 0.0000
983 DRUG DOSE OMISSION BY DEVICE 2 0.0000
984 DISEASE PROGRESSION 3 0.0000
985 DRUG DEPENDENCE 4 0.0000
986 DRUG ABUSE 2 0.0000
987 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
988 ACUTE KIDNEY INJURY 2 0.0000